Follow the people · Insider

AL

Apeiron Investment Group Ltd.

Insider · Director and 10% owner · ENHA

Apeiron Investment Group Ltd. files insider transactions with the SEC as a director and 10% owner of Enhanced Group (ENHA). We hold 6 disclosed purchases and sales filed since 12 April 2022, 6 of them in the last 90 days.

  • Files forENHA
  • Disclosed buys and sells6 in all, 6 in the last 90 days
  • Last disclosure4 September 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 7 May 20263 September 2026Director and 10% owner · Enhanced Group (ENHA)14 Form 4 lines · source: SEC Form 4
  • Filed 8 April 202230 September 202510% owner · ATAI Life Sciences (ATAI)12 Form 4 lines · source: SEC Form 4
  • Filed 2 October 20244 October 202410% owner · Bionomics Ltd/adr (BNOX)3 Form 4 lines · source: SEC Form 4
  • Filed 6 February 20246 February 2024Other role · Alto Neuroscience (ANRO)6 Form 4 lines · source: SEC Form 4
  • Filed 23 February 202323 February 202310% owner · Sensei Biotherapeutics (SNSE)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

37 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.